Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Colchicine to Prevent Post-Operative Atrial Fibrillation After CABG
NCT07611019Phase 3Enrolling by invitation
- Sponsor
- National Taiwan University Hospital
- Start
- Jul 2026
- Primary completion
- Jul 2028
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in Atrial fibrillation (AFib) comparing Colchicine Group with Placebo Group (2 arms). Primary endpoint: Incidence of new-onset atrial fibrillation at 14 days. Started Jul 2026; status: enrolling by invitation.
02
Drugs
colchicine
03
Conditions
Atrial fibrillation (AFib)
Beyond the preview
Go deeper on NCT07611019.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07611019.